-
Notifications
You must be signed in to change notification settings - Fork 0
/
index_en.html
462 lines (417 loc) · 23.6 KB
/
index_en.html
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1">
<!-- The above 3 meta tags *must* come first in the head; any other head content must come *after* these tags -->
<title>ISAS 2018</title>
<!-- favicon -->
<link href="favicon.png" rel=icon>
<!-- web-fonts -->
<link href='https://fonts.googleapis.com/css?family=Roboto:100,300,400,700,500' rel='stylesheet' type='text/css'>
<!-- Bootstrap -->
<link href="css/bootstrap.min.css" rel="stylesheet">
<!-- Style CSS -->
<link href="css/style.css" rel="stylesheet">
<!-- HTML5 shim and Respond.js for IE8 support of HTML5 elements and media queries -->
<!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
<!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.2/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body id="page-top" data-spy="scroll" data-target=".navbar">
<div id="main-wrapper">
<!-- Page Preloader -->
<div id="preloader">
<div id="status">
<div class="status-mes"></div>
</div>
</div>
<header class="header">
<!-- Navigation -->
<nav class="navbar main-menu" role="navigation">
<div class="container">
<div class="navbar-header">
<button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-main-collapse">
<span class="sr-only">Toggle navigation</span>
<span class="icon-bar"></span>
<span class="icon-bar"></span>
<span class="icon-bar"></span>
</button>
<a class="navbar-brand page-scroll" href="#page-top"><img src="img/logo.png" alt=""></a>
</div>
<!-- Collect the nav links, forms, and other content for toggling -->
<div class="collapse navbar-collapse navbar-right navbar-main-collapse">
<ul class="nav navbar-nav">
<!-- Hidden li included to remove active class from about link when scrolled up past about section -->
<li class="hidden"><a href="#page-top"></a></li>
<li><a class="page-scroll" style="color:#0e1555" href="#section-intro">Symposium</a></li>
<li><a class="page-scroll" style="color:#0e1555" href="#section-speaker">Speakers</a></li>
<li><a class="page-scroll" style="color:#0e1555" href="#section-ajenda">Programme</a></li>
<li><a class="page-scroll" style="color:#0e1555" href="#section-partner">Organizers</a></li>
<li><a class="page-scroll" style="color:#0e1555" href="#section-pricing">Register</a></li>
<li><a class="page-scroll" style="color:#0e1555" href="#section-venue">Venue</a></li>
<li><a href="index.html" style="color:red" title="">LANG: SPANISH</a></li>
</ul>
</div>
<!-- /.navbar-collapse -->
</div>
<!-- /.container -->
</nav>
<!-- .nav -->
</header>
<div class="jumbotron text-center">
<div class="content">
<div class="event-date" style="color:#0e1555" ><b>APRIL 13TH, BILBAO</b></div>
<h1 style="color:#0e1555">II International Symposium on Alpha-Synuclein</h1>
<p class="lead" style="color:#0e1555" ><b>(ISAS 2018)</b></p>
<button type="button" onclick="location.href='data/folleto_en.pdf'" style="background-color:#0e1555" class="btn btn-default btn-lg">Download programme</button>
</div>
</div>
<!-- .Jumbotron-->
<section id="section-intro" class="section-wrapper about-event">
<div class="container">
<div class="row">
<div class="col-md">
<h1>INTRODUCTION</h1>
<p class="lead">
Alpha-synuclein is a ubiquitous protein in the healthy brain that is found in the presynaptic terminals of neurons. Although its function is not well known, it is believed that it favors the formation of synaptic vesicles that contain neurotransmitters. In particular, it seems that alpha-synuclein has a special role in the regulation of the release of dopamine. Due to different pathological mechanisms, alpha-synuclein can be added forming insoluble intra and extraneuronal fibrillar structures that give rise to the Lewy bodies, characteristic of the set of diseases called synucleinopathies. The most well-known representative of synucleinopathies is Parkinson's disease, which is neither more nor less the second most frequent neurodegenerative disease in the world after Alzheimer's disease. However, the spectrum of synucleinopathies is broader than Parkinson's disease, and it also includes other less frequent diseases such as Lewy body dementia, multiple systemic atrophy, REM sleep behavior disorder and pure autonomic failure. This set of diseases, the synucleinopathies, share many neurobiological and phenotypic similarities, which favors that they often overlap each other.
</p>
<h1>PURPOSE</h1>
<p class="lead">
This symposium, which is the second edition of the meeting with the same name organized by our group at the Biocruces HRI and the Cruces University Hospital in 2016, was born as a result of a double initiative with which, on the one hand, we intend to promote dissemination and training in advances and regional and international research projects related to the pathophysiology, diagnosis and treatment of synucleinopathies, and on the other hand we want to encourage interaction and collaboration among the groups dedicated to the study of synucleinopathies, and also to stimulate students and the personnel in training in the field of biomedicine to become involved in research on synucleinopathies.
</p>
<h1>TO WHOM</h1>
<p class="lead">
- Health staff (doctors, nurses, psychologists, etc.) interested in neurosciences, especially in the field of neurology, neuropsychology, neurophysiology, neuroradiology, neurorehabilitation and neurosurgery.
</p>
<p class="lead">
- Pre-doc and post-doc researchers and undergraduate or master students in the field of biomedicine with an interest in neurosciences (Biology, Biochemistry, Biomedical Engineering, Biophysics, etc.).
</p>
</div>
</div>
</div>
</section>
<!-- .about-event -->
<section id="section-speaker" class="section-wrapper team gray-bg">
<div class="container">
<div class="row">
<div class="col-md-12">
<div class="section-title">
<h1>SPEAKERS</h1>
</div>
</div>
</div>
<div class="row">
<div class="col-sm-6 col-md-3">
<figure class="thumbnail">
<a href="#"><img src="img/juancarlos.png" class="img-responsive" alt="Image"></a>
<figcaption class="caption text-center">
<h3>JC Gómez Esteban
<small>Neurodegenerative Diseases Group, Biocruces HRI (Barakaldo, Spain)</small>
</h3>
</figcaption>
</figure>
</div>
<!-- /.col-sm-6 -->
<div class="col-sm-6 col-md-3">
<figure class="thumbnail">
<a href="#"><img src="img/beatriz.png" class="img-responsive" alt="Image"></a>
<figcaption class="caption text-center">
<h3>Beatriz Tijero
<small>Neurodegenerative Diseases Group, Biocruces HRI (Barakaldo, Spain)</small>
</h3>
</figcaption>
</figure>
</div>
<!-- /.col-sm-6 -->
<div class="col-sm-6 col-md-3">
<figure class="thumbnail">
<a href="#"><img src="img/javier.png" class="img-responsive" alt="Image"></a>
<figcaption class="caption text-center">
<h3>Javier Ruiz Martínez
<small>Movement Disorders Unit Donostia U. Hospital - Biodonostia HRI (San Sebastian, Spain)</small>
</h3>
</figcaption>
</figure>
</div>
<!-- /.col-sm-6 -->
<div class="col-sm-6 col-md-3">
<figure class="thumbnail">
<a href="#"><img src="img/vikram.png" class="img-responsive" alt="Image"></a>
<figcaption class="caption text-center">
<h3>Vikram Khurana
<small>Ann Romney Center for Neurologic Diseases, Harvard Medical School, Harvard Stem Cell Institute (Boston, USA)</small>
</h3>
</figcaption>
</figure>
</div>
<!-- /.col-sm-6 -->
</div>
<!-- .row -->
<div class="row">
<div class="col-sm-6 col-md-3">
<figure class="thumbnail">
<a href="#"><img src="img/joaquin.png" class="img-responsive" alt="Image"></a>
<figcaption class="caption text-center">
<h3>Joaquín Castilla
<small>Prion lab - CIC bioGUNE. Proteomics unit., Scientific-Technological Park of Bizkaia (Zamudio, Spain)</small>
</h3>
</figcaption>
</figure>
</div>
<!-- /.col-sm-6 -->
<div class="col-sm-6 col-md-3">
<figure class="thumbnail">
<a href="#"><img src="img/fabio.png" class="img-responsive" alt="Image"></a>
<figcaption class="caption text-center">
<h3>Fabio Cavaliere
<small>Laboratory of Neurobiology, Achucarro Basque Center for Neuroscience (Leioa, Spain)</small>
</h3>
</figcaption>
</figure>
</div>
<!-- /.col-sm-6 -->
<div class="col-sm-6 col-md-3">
<figure class="thumbnail">
<a href="#"><img src="img/nicolas.png" class="img-responsive" alt="Image"></a>
<figcaption class="caption text-center">
<h3>Nicolás Cuenca
<small>Physiology, Genetics & Microbiology Dep., Alicante University (Alicante, Spain)</small>
</h3>
</figcaption>
</figure>
</div>
<!-- /.col-sm-6 -->
<div class="col-sm-6 col-md-3">
<figure class="thumbnail">
<a href="#"><img src="img/rosario2.png" class="img-responsive" alt="Image"></a>
<figcaption class="caption text-center">
<h3>Rosario S. Pernaute
<small>Andalusian Initiative for Advanced Therapies (Sevilla, Spain)</small>
</h3>
</figcaption>
</figure>
</div>
<!-- /.col-sm-6 -->
</div>
<!-- .row -->
<div class="row">
<div class="col-sm-6 col-md-3">
<figure class="thumbnail">
<a href="#"><img src="img/maz.png" class="img-responsive" alt="Image"></a>
<figcaption class="caption text-center">
<h3>Mazahir Hasan
<small>Laboratory of Memory Circuits - Achucarro Basque Center of Neuroscience (Leioa, Spain)</small>
</h3>
</figcaption>
</figure>
</div>
<!-- /.col-sm-6 -->
<div class="col-sm-6 col-md-3">
<figure class="thumbnail">
<a href="#"><img src="img/inigo.png" class="img-responsive" alt="Image"></a>
<figcaption class="caption text-center">
<h3>Iñigo Gabilondo
<small>Neurodegenerative Diseases Group, Biocruces HRI (Barakaldo, Spain)</small>
</h3>
</figcaption>
</figure>
</div>
<!-- /.col-sm-6 -->
<div class="col-sm-6 col-md-3">
<figure class="thumbnail">
<a href="#"><img src="img/manuel.png" class="img-responsive" alt="Image"></a>
<figcaption class="caption text-center">
<h3>Manuel Fernández
<small>Dementia Unit Cruces U. Hospital - Biocruces HRI (Barakaldo, Spain)</small>
</h3>
</figcaption>
</figure>
</div>
<!-- /.col-sm-6 -->
<div class="col-sm-6 col-md-3">
<figure class="thumbnail">
<a href="#"><img src="img/rosario.png" class="img-responsive" alt="Image"></a>
<figcaption class="caption text-center">
<h3>Maria-Rosario Luquin
<small>Centro de Investigación Médica Aplicada (CIMA), University of Navarra (Pamplona, Spain)</small>
</h3>
</figcaption>
</figure>
</div>
<!-- /.col-sm-6 -->
</div>
<!-- .row -->
</div>
<!-- /.container -->
</section>
<!-- .team -->
<section id="section-ajenda" class="section-wrapper section-ajenda">
<div class="container">
<div class="row">
<div class="col-md-12">
<div class="section-title">
<h1>PROGRAMME</h1>
<a href="#"><img src="img/programme_EN.jpg" class="img-responsive" alt="Image"></a>
<br></br><button type="button" onclick="location.href='data/folleto_en.pdf'" style="background-color:#0e1555" class="btn btn-default btn-lg">Download programme</button>
</div>
</div>
</div>
</div>
<section id="section-partner" class="section-wrapper client-logo gray-bg">
<div class="container">
<div class="row">
<div class="col-md-12">
<div class="section-title">
<h1>ORGANIZERS</h1>
</div>
</div>
</div>
<div class="row">
<h1>Group of Neurodegenerative Diseases (Biocruces HRI)</h1>
<div class="col-md-6">
<a href="https://www.biocruces.org/web/biocruces/bc5.01"><img src="img/grupo.jpeg" class="img-responsive" alt="Image"></a>
</div>
<p class="lead">
Our Group of Neurodegenerative Diseases of BioCruces HRI has a trajectory of more than 10 years dedicated to the study of the phenotype of the genetic forms of Parkinson's disease. Specifically, in 2004 our group first described the E46K mutation of the alpha-synuclein gene (E46K-SNCA) in a family in the Basque Country. This mutation, a genetic anomaly rare and unique in the world, produces a Lewy body disease comparable in many pathological and clinical aspects to the more aggressive idiopathic forms of Parkinson's disease and Lewy body dementia. Therefore, the E46K-SNCA mutation is considered today one of the best in vivo genetic models of synucleinopathies. Since 2004, our group carries out an exhaustive clinical follow-up of the E46K-SNCA carriers, with neurological, neuropsychological, autonomic nervous system, brain neuroimaging and retinal evaluations, among others, which has been continuously supported by institutions such as the Michael J Fox Foundation, the Carlos III Institute and the Basque Government. At present, through collaborations with centers such as the Harvard Stem Cell Institute, the University of Luxembourg or the Achucarro Basque Center for Neuroscience, we are expanding the study of the E46K-SNCA carriers to establish correlations between our clinical findings and the cellular and molecular bases of the mutation and to identify mechanisms and possible therapeutic solutions for the set of synucleinopathies.
</p>
</div>
<div class="col-md-4 col-sm-4 section-margin">
<a href="http://neurolagun.eus"><img src="img/OSAKIDETZA_NEUROLAGUN.png" alt="Image"></a>
</div>
<div class="container">
<div class="row">
<div class="col-md-12">
<div class="section-title">
<br></br>
<h1>ACKNOWLEDGEMENTS</h1>
<br></br>
<p class="lead">
The organizing committee of ISAS 2018 would like to acknowledge the
following companies for their support:
</p>
</div>
</div>
</div>
<div class="row">
<div class="col-md-12">
<a href="#"><img src="img/PHARMA.png" class="img-responsive" alt="Image" style="text-align: center; display: block; margin: auto"></div></a>
</div>
<br></br>
<p class="lead">
Additional acknowledgements to the following institutions for their financial
support in the research of synucleinopathies:
</p>
</div>
<div class="col-md-12">
<a href="#"><img src="img/SUPPORT_RESEARCH.png" class="img-responsive" alt="Image" style="text-align: center; display: block; margin: auto"></div></a>
</div>
<!--end of .container -->
</section>
<!-- .client-logo -->
<section id="section-pricing" class="section-wrapper client-logo">
<div class="container">
<div class="row">
<div class="col-md-12">
<div class="section-title">
<h1>REGISTRATION & CONTACT</h1>
<p class="lead">
-Price: FREE
</p>
<p class="lead">
-LIMITED PLACES (80 ATTENDEES)
</p>
<p class="lead">
-DEADLINE FOR REGISTRATION: APRIL 12TH, 2018
</p>
<p class="lead">
-REGISTRATION IS MANDATORY in order to be able to attend the symposium
</p>
<p class="lead">
-For any QUESTIONS about symposium & registration, CONTACT US with an email to movdisorders.biocruces@gmail.com
</p>
<p class="lead">
-REGISTER ONLINE in the following link: </p>
</div>
</div>
</div>
</div>
<div class="row">
<div class="col-sm">
<div class="pricing-table-default text-center">
<div class="pricing-head">
<span class="price"><sup>
</div>
<div class="pricing-detail">
</div>
<a href="https://www.eventbrite.es/e/entradas-ii-international-symposium-on-alpha-synuclein-42378206356?utm-medium=discovery&utm-campaign=social&utm-content=attendeeshare&aff=escb&utm-source=cp&utm-term=eventcard" class="btn btn-primary">Book ticket (FREE)</a>
</div>
<!-- /.pricing-table-wrapper -->
</div>
<!-- .col-sm-4 -->
</div>
<!-- /.row -->
</div>
<!-- /.container -->
</section>
<!-- .pricing-section -->
<section id="section-venue" class="section-wrapper client-logo gray-bg">
<div class="container">
<div class="row">
<div class="col-md-12">
<div class="section-title">
<h1>VENUE</h1>
<br></br>
<p>SALÓN DE ACTOS. CRUCES UNIVERSITY HOSPITAL. PLAZA DE CRUCES 12, BARAKALDO (SPAIN)<br></br>The Cruces University Hospital is located in the neighborhood of the same name in the municipality of Barakaldo, 10 kilometers from Bilbao.
Its access by road can be easily done by car, since it is located next to the A-8 motorway. Under the square in front of the Hospital there is a paid parking and the neighborhood also has several parking areas that allow half-day stays. There are also stops for public buses coming from all the towns of its surroundings and there is a taxi service inside the hospital enclosure.
<br></br> The most practical way to get to the Hospital from Bilbao is by metro (“Gurutzeta/Cruces” stop)</p>
</div>
<p></p>
</div>
<!-- /.row-->
<div class="col-md-6">
<a href="#"><img src="img/METRO.png" class="img-responsive" alt="Image" style="text-align: center; display: block; margin: auto"></div></a>
</div>
<br></br>
<div class="col-md-6">
<a href="#"><img src="img/MAP.png" class="img-responsive" alt="Image" style="text-align: center; display: block; margin: auto"></div></a>
</div>
<br></br>
<div class="row">
<div class="col-md-12">
<div id="googleMap"></div>
</div>
</div>
<!-- .row-->
</div>
</section>
<!-- contact-section -->
<footer class="footer">
<div class="copyright-section">
<div class="container">
<div class="col-md-12">
<div class="copytext text-center">© ISAS 2018. All rights reserved | Design By: <a href="https://uicookies.com">uiCookies</a></div>
</div>
</div>
<!-- .container -->
</div>
<!-- .copyright-section -->
</footer>
<!-- .footer -->
</div>
<!-- #main-wrapper -->
<!-- jquery -->
<script src="js/jquery-2.1.4.min.js"></script>
<!-- Bootstrap -->
<script src="js/bootstrap.min.js"></script>
<!-- Plugin JavaScript -->
<script src="js/jquery.easing.min.js"></script>
<!-- Google Maps API Key - Use your own API key to enable the map feature. More information on the Google Maps API can be found at https://developers.google.com/maps/ -->
<script type="text/javascript" src="https://maps.googleapis.com/maps/api/js?key=AIzaSyAW7f1_6Dgc_29hxL-GPqPmCZagGY6hvbo&sensor=false"></script>
<!--<script src="js/one-page-nav.js"></script>-->
<script src="js/scripts.js"></script>
</body>
</html>